Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Todd Asset Management LLC trimmed its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 553,077 shares of the biopharmaceutical company’s stock after selling 2,006 shares during the period. Todd […]
Ausdal Financial Partners Inc. lowered its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,616 shares of the biopharmaceutical company’s stock after selling 686 shares during the […]
Ausdal Financial Partners Inc. decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,616 shares of the biopharmaceutical company’s stock after selling 686 shares during the period. Ausdal […]
Fortitude Advisory Group L.L.C. decreased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 5.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,654 shares of the biopharmaceutical company’s stock after selling 218 shares during the period. Fortitude […]
Bristol-Myers Squibb (NYSE:BMY – Free Report) – Analysts at Cantor Fitzgerald lifted their FY2024 earnings estimates for shares of Bristol-Myers Squibb in a research note issued to investors on Monday, October 16th. Cantor Fitzgerald analyst O. Brayer now forecasts that the biopharmaceutical company will post earnings per share of $7.82 for the year, up from […]